Main Topics

Print
PREVENTION
• Screening – Big data Questions
• Level of risk – High/ Medium/ Low
• Population – Age/ Obese/ GDM
• Lifestyle Intervention
• Drug Therapy – Metformin / Thiazolidinedione / GLP1 / Anti Obesity Drugs /SGLT2
• Digital Screening and Intervention

EARLY DETECTION
• Big Data / Screening
• A1C Target
• Early Intervention Double / Triple Combination Therapy, Insulin
• Personalized Therapy Drugs vs Bariatric Surgery
• Treatment Intensification
• Prevention / Treatment Micro / Macrovascular Diabetes
• Digital Therapy

LONG DISEASE DURATION / COMPLICATION
• A1C Target – CVRF Target - Lifestyle – Drug Therapy - Bariatric Surgery 
    – With / Without Early Microvascular Complication 
    – With / Without Macrovascular Complication 
    – With / Without NASH / Progressive Microvascular Diabetes

• New Targets / New drugs – Early complications 
    – Detectable / Undetectable Urine Albumin 
    – Clinical Neuropathy vs EMG Sensory / Motor / Autonomic

PROGRESSIVE COMPLICATION DIAGNOSIS / THERAPY
• Congestive Heart Failure – Diastolic / Systolic
• Progressive Retinopathy – A1C / HT / Lipid Target / Insulin (A1C Targets)
• Progressive Autonomic Neuropathy – Vascular, GI, GU
• Dialysis Prevention in Patients with EGFR > 30 > 45
• OHG Drugs or Other Drugs, Risk vs Benefit